| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702186 | Practical Radiation Oncology | 2017 | 28 Pages |
Abstract
All 3 regimens demonstrated similar excellent local control with minimal toxicity; however, the ability of hSRT to treat larger tumors with comparable outcomes to SRS and greater patient convenience when compared with cfSRT suggest that hSRT may offer the optimal treatment approach.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Benjamin G. MD, MS, Uma MD, Joel L. MD, Christopher MD, PhD, Craig R. MD, PhD, John MS, Abhay MD, Baldassarre MD, PhD,